Scarica l'app Stockscreener
12.16
8.26%
0.9284
Dopo l'orario di chiusura:
12.16
-0.0034
-0.03%
Precedente Chiudi:
$11.23
Aprire:
$12.61
Volume 24 ore:
4,721
Relative Volume:
0.97
Capitalizzazione di mercato:
$8.27B
Reddito:
$277.56M
Utile/perdita netta:
$-13.33M
Rapporto P/E:
-64.02
EPS:
-0.19
Flusso di cassa netto:
$-6.54M
1 W Prestazione:
+21.39%
1M Prestazione:
+35.75%
6M Prestazione:
+57.15%
1 anno Prestazione:
+39.01%
Intervallo 1D:
$12.16
$12.61
Intervallo di 1 settimana:
$10.60
$12.61
Portata 52W:
$6.65
$12.61
Pharming Group N V Adr Stock (PHAR) Company Profile
Nome
Pharming Group N V Adr
Settore
Industria
Telefono
-
Indirizzo
-
Confronta PHAR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PHAR
Pharming Group N V Adr
|
12.16 | 685.31M | 277.56M | -13.33M | -6.54M | -0.19 |
|
ONC
Beone Medicines Ltd Adr
|
258.27 | 26.01B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
445.85 | 114.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.3499 | 41.83M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
83.98 | 6.29B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
484.93 | 63.90B | 14.09B | 4.50B | 2.96B | 39.28 |
Pharming Group N V Adr Stock (PHAR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-09 | Iniziato | Jefferies | Buy |
Pharming Group N V Adr Borsa (PHAR) Ultime notizie
PHAR stock hits 52-week high at $11.14 amid robust growth - Investing.com India
Pharming To Attend The H.C. Wainwright BioConnect Investor Conference 2023 - Barchart.com
SpringWorks Therapeutics (SWTX) Soars 9.0%: Is Further Upside Left in the Stock? - Nasdaq
META_TITLE_SECTORS - Yahoo Finance
Pharming Group to participate in March investor conference - GlobeNewswire Inc.
Pharming Group (OTCMKTS:PHGUF) Shares Cross Above 50 Day Moving Average – Time to Sell? - Defense World
Pharming Group N.V. (AMS:PHARM) Held Back By Insufficient Growth Even After Shares Climb 26% - Simply Wall St
Pharming Group stock gains on KL1333’s blockbuster potential, says RBC - Investing.com India
H.C. Wainwright reiterates Buy on Pharming stock, pediatric trial shows safety and tolerability - Investing.com India
Jefferies initiates Pharming Group shares with Buy on revenue growth - Investing.com India
Oppenheimer cuts Pharming Group stock target, Outperform on Q3 results - Investing.com
Novavax (NVAX) Moves 19.2% Higher: Will This Strength Last? - Yahoo Finance
RGC Stock Quote Price and Forecast - CNN
symbol__ Stock Quote Price and Forecast - CNN
Why Earnings Season Could Be Great for Pharming Group (PHAR) - Yahoo Finance
Can Pharming Group N.V. Sponsored ADR (PHAR) Run Higher on Rising Earnings Estimates? - Yahoo Finance
Are Medical Stocks Lagging Lantheus (LNTH) This Year? - Nasdaq
Pharming Group (PHAR) - Zacks Investment Research
PHARM Stock Price and Chart — EURONEXT:PHARM - TradingView
Pharming Group N V Adr Azioni (PHAR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.00%
0.54%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):